NCT00057473
- Conditions
- Neoplasms
- Locations
-
- Local Institution Orlando, Florida, United States
- Local Institution Houston, Texas, United States
Clinical trial condition
Neoplasms
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
818 public trials
114 recruiting studies
Neoplasms trial results
NCT00024648
- Conditions
- Neoplasms
- Locations
-
- Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Temple University Cancer Center Philadelphia, Pennsylvania, United States
Completed
Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors
NCT00024661
- Conditions
- Neoplasms
- Locations
-
- Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- Temple University Cancer Center Philadelphia, Pennsylvania, United States
NCT00528619
- Conditions
- Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Pfizer Investigational Site Aurora, Colorado, United States
- Pfizer Investigational Site Ottawa, Ontario, Canada
- Pfizer Investigational Site Montreal, Quebec, Canada
NCT00417079
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
- Locations
-
- sanofi-aventis US Bridgewater, New Jersey, United States
- sanofi-aventis Argentina Buenos Aires, Argentina
- sanofi-aventis Belgium Diegem, Belgium
- sanofi-aventis Brazil São Paulo, Brazil
NCT00088790
- Conditions
- Neoplasms
- Locations
-
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States
Completed
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients
NCT00479076
- Conditions
- Neoplasms
- Locations
-
- Sanofi-Aventis Administrative Office Tokyo, Japan
Completed
Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan
NCT01018745
- Conditions
- Neoplasms
- Locations
-
- Local Institution Chuo-Ku, Tokyo, Japan
NCT00421811
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- University of Colorado, Denver Aurora, Colorado, United States
- University of Florida College of Medicine Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Duke University Medical Center Durham, North Carolina, United States
NCT00265057
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
- Locations
-
- Istituto Nazionale per lo Studio e la Cura dei Tumori Milan, Italy
- Instituto Europeo di Oncologia Milan, Italy
- Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland